A Phase 2, Multi-Center, Single-Blind, Placebo-Controlled Pharmacodynamic Evaluation of ICA-105665 in Epilepsy Patients With a Photo-Induced Paroxysmal Electroencephalographic (EEG) Response

Trial Profile

A Phase 2, Multi-Center, Single-Blind, Placebo-Controlled Pharmacodynamic Evaluation of ICA-105665 in Epilepsy Patients With a Photo-Induced Paroxysmal Electroencephalographic (EEG) Response

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Oct 2012

At a glance

  • Drugs ICA 105665 (Primary)
  • Indications Reflex epilepsy
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2011 Clinical study results for ICA 105665 will be summarized at the Antiepileptic Drug Trials XI Conference in April 2011, according to a Icagen media release.
    • 07 Mar 2011 Status changed from suspended to completed.
    • 02 Feb 2011 The FDA's clinical hold on the IND for ICA 105665 has been removed, according to an Icagen media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top